Ranbaxy Laboratories Ltd (RANB.NS)
1 Apr 2015
BRUSSELS, Sept 6 Europe's top court will rule on Thursday whether Danish drugmaker Lundbeck breached EU antitrust rules by paying smaller rivals to delay generic copies of its blockbuster citalopram anti-depressant from entering the market.
* Says Daiichi Sankyo received a final award in the arbitration that it filed with the International Court of Arbitration of the International Chamber of Commerce in November 2012 against the former shareholders Ranbaxy Laboratories Ltd. on May 3
MUMBAI The former owners of Indian drugmaker Ranbaxy Laboratories have been ordered by an arbitration court to pay damages worth 25.63 billion rupees ($385 million) to Japan's Daiichi Sankyo Co Ltd, they said on Thursday.